News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Verdict Confirms CELLECTIS SA’s Fight To Protect Its Intellectual Property
November 12, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Paris, November 12, 2009 – Cellectis S.A. (Alternext: ALCLS), the French genome engineering specialist, has announced that the Paris Tribunal de grande instance has dismissed the lawsuit filed by Genoway in January 2009.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
MORE ON THIS TOPIC
Patents
AbbVie Adds Four Years of Exclusivity to Rinvoq Franchise With Generics Settlement
September 12, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Trump Carves Tariff Exemptions for Some Pharma Products
September 12, 2025
·
2 min read
·
Tristan Manalac
China
Trump Reportedly Preparing Order Restricting Chinese Drug Licensing Deals
September 11, 2025
·
2 min read
·
Dan Samorodnitsky
Pain
FDA Looks To Streamline Development of Non-Opioid Painkillers
September 11, 2025
·
2 min read
·
Tristan Manalac